Skip to main content
Clinical Trials/NCT01784367
NCT01784367
Completed
Not Applicable

Extracorporeal Lung Assist to Avoid Intubation in Patients Failing Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure

Universitätsklinikum Hamburg-Eppendorf1 site in 1 country50 target enrollmentDecember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypercapnia
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Enrollment
50
Locations
1
Primary Endpoint
Number of Patients With Need for Intubation for Invasive Mechanical Ventilation
Status
Completed
Last Updated
last year

Overview

Brief Summary

The study´s intention is to evaluate the feasibility, safety and effectiveness of a pump driven extracorporeal device for removal of carbon dioxide from the blood in oder to avoid intubation and invasive mechanical ventilation in patients with acute respiratory failure retaining carbon dioxide due to the failure of their ventilatory muscle pump and not responding to prior non-invasive mask ventilation.

Detailed Description

The study´s intention is to evaluate the feasibility, safety and effectiveness of a pump driven extracorporeal device for removal of carbon dioxide from the blood in oder to avoid intubation and invasive mechanical ventilation in patients with acute respiratory failure retaining carbon dioxide due to the failure of their ventilatory muscle pump and not responding to prior non-invasive mask ventilation. Since intubation with subsequent (prolonged) invasive mechanical ventilation is associated with considerable side effects this new strategy has the potential to improve overall clinical outcome in this selected patient group.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
April 2015
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stefan Kluge

PD Dr. Stefan Kluge

Universitätsklinikum Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • acute or acute-on-chronic hypercapnic respiratory insufficiency (pH ≤ 7,35, PaCO2 \> 45 mmHg)
  • failure of noninvasive ventilation
  • fulfilling criteria for endotracheal intubation

Exclusion Criteria

  • under 18 years of age
  • prior inclusion in other interventional study
  • pregnancy
  • heparin allergy or heparin-induced thrombocytopenia type 2
  • on home non-invasive ventilator
  • "Do not resuscitate" order or moribund condition
  • life expectancy less than 6 months
  • no informed consent available

Outcomes

Primary Outcomes

Number of Patients With Need for Intubation for Invasive Mechanical Ventilation

Time Frame: 21 days

The number of patients in the ECLA-group who had to be intubated and mechanically ventilated under the given criteria for inclusion and exclusion is collected. Since every patient in the matched control group was intubated, the comparison of the groups shows whether the use of a pump-driven venovenous extracorporeal lung assist can reduce the frequency of intubation and mechanical ventilation.

Secondary Outcomes

  • Length of Non-invasive Ventilation(90 days)
  • Mortality(90 days)
  • Complication Rates(90 days)
  • Length of Invasive Mechanical Ventilation if Intubated(90 days)
  • Length of Stay in ICU(90 days)

Study Sites (1)

Loading locations...

Similar Trials